novo-nordisk a/s-spons adr
(NVO:New York)
Last $161.87 USD
Change Today +0.17 / 0.11%
Volume 243.9K
As of 8:04 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).
Key News About novo-nordisk a/s-spons adr
No news article found for NVO.
| Recently Viewed | |||
| NVO:US | $161.87 USD | +0.17 |  |
| Company | Last | Change |
| AstraZeneca PLC | 3,251 GBp | +4.00 |
| Bristol-Myers Squibb Co | $46.85 USD | +0.41 |
| Eli Lilly & Co | $52.35 USD | -0.01 |
| Reckitt Benckiser Group PLC | 4,748 GBp | +69.00 |
| Takeda Pharmaceutical Co Ltd | ¥4,450 JPY | +100.00 |
| View Industry Companies | ||
Industry Analysis
NVO
Industry Average
| Valuation | NVO | Industry Range |
| Price/Earnings | 22.8x |
|
| Price/Sales | 6.4x |
|
| Price/Book | 15.1x |
|
| Price/Cash Flow | 18.4x |
|
| TEV/Sales | 5.1x |
|
Post a JobJobs
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
- Orlando, FL | Consult SoftPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
